{"id":"https://openalex.org/W23167644","doi":null,"title":"[The formulation aspects of drug liberation].","display_name":"[The formulation aspects of drug liberation].","publication_year":1993,"publication_date":"1993-05-01","ids":{"openalex":"https://openalex.org/W23167644","mag":"23167644","pmid":"https://pubmed.ncbi.nlm.nih.gov/8362653"},"language":"hu","primary_location":{"id":"pmid:8362653","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8362653","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta pharmaceutica Hungarica","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024795186","display_name":"Istv\u00e1n Andr\u00e1s R\u00e1cz","orcid":"https://orcid.org/0000-0001-9740-6995","observed_orcids":["https://orcid.org/0000-0001-9740-6995"]},"institutions":[{"id":"https://openalex.org/I101202996","display_name":"Semmelweis University","ror":"https://ror.org/01g9ty582","country_code":"HU","type":"education","lineage":["https://openalex.org/I101202996"]}],"countries":["HU"],"is_corresponding":true,"raw_author_name":"I R\u00e1cz","raw_affiliation_strings":["Semmelweis Orvostudom\u00e1nyi Egyetem, Gy\u00f3gyszer\u00e9szeti Int\u00e9zet, Budapest"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Semmelweis Orvostudom\u00e1nyi Egyetem, Gy\u00f3gyszer\u00e9szeti Int\u00e9zet, Budapest","institution_ids":["https://openalex.org/I101202996"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5024795186"],"corresponding_institution_ids":["https://openalex.org/I101202996"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00119976,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"63","issue":"3","first_page":"139","last_page":"50"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.8227999806404114,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.8227999806404114,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.17430000007152557,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/controlled-drug-release","display_name":"controlled drug release","score":0.8870000243186951},{"id":"https://openalex.org/keywords/sustained-release-dosage-forms","display_name":"sustained release dosage forms","score":0.7229999899864197},{"id":"https://openalex.org/keywords/pharmaceutical-formulations","display_name":"drug formulation","score":0.8889999985694885},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7480000257492065},{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.5820000171661377},{"id":"https://openalex.org/keywords/particle-size","display_name":"particle size","score":0.5770000219345093},{"id":"https://openalex.org/keywords/polymorphism","display_name":"polymorphism","score":0.8299999833106995},{"id":"https://openalex.org/keywords/pharmaceutical-excipients","display_name":"pharmaceutical excipients","score":0.5120000243186951},{"id":"https://openalex.org/keywords/manufacturing-reproducibility","display_name":"manufacturing reproducibility","score":0.7799999713897705},{"id":"https://openalex.org/keywords/theophylline","display_name":"theophylline","score":0.9800000190734863},{"id":"https://openalex.org/keywords/nitrofurantoin","display_name":"nitrofurantoin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/phenacetin","display_name":"phenacetin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/antacids","display_name":"antacids","score":1.0}],"concepts":[{"id":"https://openalex.org/C2776711897","wikidata":"https://www.wikidata.org/wiki/Q5974727","display_name":"Liberation","level":3,"score":0.8224461078643799},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.6059557199478149},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.5393045544624329},{"id":"https://openalex.org/C2778095195","wikidata":"https://www.wikidata.org/wiki/Q407308","display_name":"Theophylline","level":2,"score":0.5355603098869324},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5124090313911438},{"id":"https://openalex.org/C2775922563","wikidata":"https://www.wikidata.org/wiki/Q419175","display_name":"Phenacetin","level":2,"score":0.5025827884674072},{"id":"https://openalex.org/C163588942","wikidata":"https://www.wikidata.org/wiki/Q5165929","display_name":"Controlled release","level":2,"score":0.48480239510536194},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4568517804145813},{"id":"https://openalex.org/C2910701995","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutics","level":5,"score":0.42228570580482483},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.42099079489707947},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.4011209011077881},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.3767205476760864},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3277353346347809},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.2359066605567932},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.17674469947814941},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.11396834254264832},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0913110077381134},{"id":"https://openalex.org/C160492267","wikidata":"https://www.wikidata.org/wiki/Q319616","display_name":"Pharmacognosy","level":4,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000863","descriptor_name":"Antacids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009582","descriptor_name":"Nitrofurantoin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010615","descriptor_name":"Phenacetin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013806","descriptor_name":"Theophylline","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:8362653","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8362653","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta pharmaceutica Hungarica","raw_type":"English Abstract"},{"id":"mag:23167644","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8362653","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.46810001134872437,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1942517029","https://openalex.org/W2088443247","https://openalex.org/W2147670387","https://openalex.org/W3187740697","https://openalex.org/W1994773393","https://openalex.org/W2160971576","https://openalex.org/W2075039266","https://openalex.org/W2006204029"],"related_works":["https://openalex.org/W2580047592","https://openalex.org/W3215469384","https://openalex.org/W1988331193","https://openalex.org/W2182542165","https://openalex.org/W129570569","https://openalex.org/W4390966901","https://openalex.org/W7096885777","https://openalex.org/W7210922588","https://openalex.org/W2402373292","https://openalex.org/W4254962328"],"abstract_inverted_index":{"Author":[0],"raised":[1],"problems":[2],"and":[3,35,78,84,98],"showed":[4],"through":[5,107],"research":[6],"data":[7],"some":[8],"simple":[9],"possibilities":[10,106],"to":[11,93,114],"achieve":[12,94],"controlled":[13,130],"release":[14,131],"drug":[15,22,132],"liberation.":[16,133],"The":[17,43,87,102],"dosage":[18,44],"form":[19],"developed":[20],"during":[21],"formulation":[23,90],"work":[24],"may":[25,37],"influence":[26],"the":[27,32,39,49,61,74,79,95,105,123],"biological":[28],"effects":[29],"exerted":[30],"by":[31],"active":[33,53],"ingredients":[34,54],"therefore":[36],"alter":[38],"therapeutic":[40],"efficacy,":[41],"too.":[42],"from":[45],"itself":[46],"includes":[47],"all":[48],"chemical":[50],"properties":[51],"of":[52,76,81,89,100,125],"(salt-,":[55],"ester":[56],"form,":[57],"polar-apolar":[58],"material":[59],"etc.),":[60,73],"physical":[62],"state":[63,72],"(crystal,":[64],"amorphous,":[65],"polymorphous,":[66],"particle":[67],"size,":[68],"surface":[69],"area,":[70],"solvated":[71],"value":[75],"stability":[77],"parameters":[80],"auxiliary":[82],"materials":[83],"manufacturing":[85],"processes.":[86],"aim":[88],"-among":[91],"others-is":[92],"optimal":[96],"liberation":[97],"bioavailability":[99],"drugs.":[101],"article":[103],"reviews":[104],"examples":[108],"(theophylline,":[109],"nitrofurantoin,":[110],"phenacetin,":[111],"antacids)":[112],"how":[113],"make":[115],"production":[116],"prescriptions":[117],"with":[118,129],"high":[119],"reproducibility":[120],"used":[121],"for":[122],"preparation":[124],"prolonged":[126],"action":[127],"systems":[128]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}